CHU UCL Namur
Yvoir, Namur, 5530, Belgium
Location status: Recruiting
Location contact
Laura Santelé, MSc
CONTACT
Yves Vandermeeren, MD, PhD
CONTACT
NCT Number: NCT07826832
To test the capacity of healthy individuals, chronic and acute stroke patients to learn and retain a complex unimanual or bimanual motor skill, trained on the neurorehabiliation robot REAplan® et the Dextrain® device. The goals are (1) to compare head-to-head bimanual versus unimanual motor learning (in the proximal and distal upper limb, UL) during the acute - early subactue stage of stroke with robotics and (2) to identify the neural substrates associated with (and deficits in) unimanual versus bimanual motor control (proximal and distal) after stroke by means of multimodal brain imaging.
Interested in participating?
Request Info40 year–90 year
All sexes
Interventional
Not applicable
Yvoir, Namur, 5530, Belgium
Location status: Recruiting
Laura Santelé, MSc
CONTACT
Yves Vandermeeren, MD, PhD
CONTACT
Over 3 consecutive days, healthy individuals, acute and chronic stroke patients (1) will be evaluated and (2) will train on the neurorehabiliation robot REAplan® and Dextrain® device.
They will practice a task on the robot REAplan® (unimanual or bimanual version), requiring movements with the affected arm (unimanual version) and complex, coordinated movements with both arms (bimanual version). They will practice another task on the Dextrain® device, also in unimanual and bimanual version.
In addition, several standardized clinical scales and tests will be used to evaluate overall motor-sensory-cognitive functions (clinical tests, questionnaires, ...)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
STROKE PATIENTS
Inclusion criteria
Exclusion criteria
HEALTHY INDIVIDUALS
Inclusion criteria
Exclusion criteria
motor skill learning with the REAplan® rehabilitation robot, to be performed with one or two arms
motor skill learning with the Dextrain® Manipulandum dexterity tool to be performed with on or two hands
Time frame: Change between baseline (Day 1) and after training (Day 3) and transfer from Day 3 to Day 1 on the untrained mode
Unimanual/bimanual Speed/Accuracy Trade-off: mathematical computation of the relationship between speed and accuracy, in arbitrary units (SAT = speed (cm/s)/error (cm²).C, where C=1cm.s)
Time frame: change between baseline (Day 1) and after training (Day 3)
bimanual Coordination factor, mathematical measure of the phase coherence between speeds of both arms
Time frame: change between baseline (Day 1) and after training (Day 3)
bimanual forces, forces exerted in the wrong direction by each arm (Newtons)
Time frame: change between baseline (Day 1) and after training (Day 3) and transfer between Day 3 and Day 1 on the untrained mode
tracking error between the optimal trajectory between 2 targets and the actual trajectory
Time frame: change between baseline (Day 1) and after training (Day 3)
bimanual Coordination factor, mathematical measure of the phase coherence between speeds of both hands
Time frame: change between baseline (Day 1) and after training (Day 3) and transfer between Day 3 and Day 1 on the untrained mode
The amount of time the cursor remains inside the target zone
Time frame: change between baseline (Day 1) and after training (Day 3) and transfer between Day 3 and Day 1 on the untrained mode
binary measure of unasked fingers activated above the force threshold
Time frame: Baseline
Diffusion Weighted Imaging (DWI)
Time frame: Baseline
Fractional Anisotrophy, Mean/Axial/Radial Diffusivity
Time frame: Day1
Tests impairments of the upper limb after stroke. Range: 0-66. A higher score means less impairment
Time frame: Day1
Measures unilateral gross dexterity by moving as many small wooden blocks as possible from one side to the other side of the box within 60 seconds. The task is performed seperately with each hand. Score range: 0-150 for each hand. The score corresponds to the number of blocks successfully transferred in one minute. A higher score indicates better gross manual dexterity and upper-limb function.
Time frame: Day1
Measures the fingertip dexterity and gross movement of the hand, fingers and arm. 4 different subtasks
Time frame: Day2
A first-line, stroke-specific and domain-specific cognitive screening tool, inclusive for patients with aphasia and neglect. Domains assessed: Language, Praxis, Number, Memory, Spatial and Controlled Attention. It provides a cognitive profile showing both preserved and impaired abilities
Time frame: Day2
A paper-pen test to asses processing speed and working memory.
Time frame: Every days, mean of the three days
A psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points. Range : 0- 10. A higher score means a higher level of fatigue.
Time frame: Day 1
A prognostic determinant of the function of the hemiparetic upper limb (UL) after a stroke. For each of the 2 subitems, the range is 0-5. A score of 5 means normal power. A score of 0 means no contraction possible.
Time frame: Day 1
clinical measure of spasticity. For each of the 8 subitems, the range is 0-4. A higher score means a higher level of spasticity
Time frame: Day 3
The Intrinsic Motivation Inventory (IMI) is a multidimensional measurement device intended to assess participants' subjective experience related to a target activity in laboratory experiments
Contact information is provided by the study sponsor or research team.
Laura Santelé, MSc
CONTACT
Yves Vandermeeren, MD, PhD
CONTACT
University Hospital of Mont-Godinne
Other
Comparison of Unimanual Versus Bimanual Motor Skill Learning (Proximal and Distal) After Stroke by Means of Robotics (REA²Plan® and Dextrain®) and Multimodal Brain Imaging (VLSM, DTI, NODDI, DIAMOND)
Acronym: MLAS6
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05065216
Acute Stroke, Brain Diseases
Fairhope, Alabama, United States
View Trial DetailsNCT07065929
Acute Stroke, Brain Diseases
Chesnay, Yvelines, France
View Trial DetailsNCT07764172
Acute Stroke, Atrophy
Moscow, Russia
View Trial DetailsNCT07491952
Acute Stroke, Brain Diseases
Huntsville, Alabama, United States
View Trial Details